Charlie Hatton
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Multiple Myeloma Research and Treatments, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity(2012)8,404 cited
- → Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma(2007)1,081 cited
- → High-throughput oncogene mutation profiling in human cancer(2007)995 cited
- → Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy(2010)716 cited
- → Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway(2012)630 cited
- → MEK1 mutations confer resistance to MEK and B-RAF inhibition(2009)630 cited
- → Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer(2011)472 cited
- → A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia(2019)438 cited
- → Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples(2009)432 cited
- → Drug-sensitiveFGFR2mutations in endometrial carcinoma(2008)342 cited